Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1275 of 1958 entries
View as:

A Study of Insulin Efsitora Alfa (LY3209590) as a Weekly Basal Insulin Compared to Insulin Glargine in Adult Participants With Type 2 Diabetes on Multiple Daily Injections

Phase: N/A Priority: Normal
NCT ID: NCT05462756 Org: User:
Start: 08/11/22 End: 02/27/24 Due: 02/27/25

A Safety Study in Participants With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01284335 Org: User:
Start: 07/31/08 End: 05/31/16 Due: 05/31/17

Urge Incontinence Bladder Overactivity Study

Phase: N/A Priority: Normal
NCT ID: NCT00475696 Org: User:
Start: 11/30/02 End: 03/31/05 Due: 03/31/06

A Study to Evaluate the Effect of Genotype on LY2216684

Phase: N/A Priority: Normal
NCT ID: NCT01460381 Org: User:
Start: 10/31/11 End: 08/31/12 Due: 08/31/13

A Study of Ramucirumab Combination Therapy in Japanese Participants Who Have Advanced Stomach Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02359058 Org: User:
Start: 02/28/15 End: 11/30/16 Due: 11/30/17

Effect of Retatrutide Compared With Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Inhibitor (TRANSCEND-T2D-2)

Phase: N/A Priority: Normal
NCT ID: NCT06260722 Org: User:
Start: 02/21/24 End: 01/31/27 Due: 01/31/28

A Safety Evaluation of Drotrecogin Alfa (Activated) in Patients With Blood Cancer, Severe Infection Related to Bone Marrow Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT00067730 Org: User:
Start: 03/31/03 End: 10/31/03 Due: 10/31/04

A Drug Interaction Study to Assess the Effect of LY317615 on the Metabolic Pathway of Warfarin

Phase: N/A Priority: Normal
NCT ID: NCT01388335 Org: User:
Start: 08/31/11 End: 12/31/12 Due: 12/31/13

A Study of Tirzepatide (LY3298176) in Healthy Lactating Females

Phase: N/A Priority: Normal
NCT ID: NCT05978713 Org: User:
Start: 07/31/23 End: 03/12/24 Due: 03/12/25

Duloxetine Versus Placebo for Fibromyalgia

Phase: N/A Priority: Normal
NCT ID: NCT00489073 Org: User:
Start: 11/30/02 End: 12/31/03 Due: 12/31/04

A Study to Evaluate the Safety and Tolerability of LY3000328 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT01515358 Org: User:
Start: 02/29/12 End: 05/31/12 Due: 05/31/13

A Safety Study of LY3372689 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT04106206 Org: User:
Start: 10/23/19 End: 02/12/20 Due: 02/12/21

A Study to Measure Calorie Consumption and Usage in Participants With Obesity Using LY3437943

Phase: N/A Priority: Normal
NCT ID: NCT06313528 Org: User:
Start: 03/20/24 End: 10/31/25 Due: 10/31/26

A Study of Doxorubicin Plus Olaratumab (LY3012207) in Participants With Advanced or Metastatic Soft Tissue Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT02451943 Org: User:
Start: 09/14/15 End: 06/27/24 Due: 06/27/25

A Study in Advanced Cancers Using Ramucirumab (LY3009806) and Other Targeted Agents

Phase: N/A Priority: Normal
NCT ID: NCT02745769 Org: User:
Start: 10/21/16 End: 01/22/19 Due: 01/22/20

A Study of Donanemab (LY3002813) in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT05567159 Org: User:
Start: 10/04/22 End: 07/14/23 Due: 07/14/24

Atomoxetine Phase 2 Study in Japanese Adult Patients With Attention Deficit/Hyperactivity Disorder (ADHD)

Phase: N/A Priority: Normal
NCT ID: NCT00530335 Org: User:
Start: 09/30/07 End: 04/30/08 Due: 04/30/09

A Phase 3 Trial of LY900003 Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00034268 Org: User:
Start: 03/31/02 End: - Due: -

A Study of Tadalafil and Sildenafil in Men With Erectile Dysfunction in China

Phase: N/A Priority: Normal
NCT ID: NCT01352507 Org: User:
Start: 06/30/11 End: 07/31/12 Due: 07/31/13

A Study of LY3002813 in Participants With Memory Damage Due to Alzheimer's Disease (AD) or AD

Phase: N/A Priority: Normal
NCT ID: NCT02624778 Org: User:
Start: 12/22/15 End: 08/28/19 Due: 08/28/20

Safety and Efficacy Study of Insulin Lispro Versus Insulin Aspart in Participants With Type 2 Diabetes on Insulin Pump Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01474538 Org: User:
Start: 12/31/11 End: 02/28/13 Due: 02/28/14

A Study of Ixekizumab in Participants With Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT02993471 Org: User:
Start: 12/22/16 End: 11/21/17 Due: 11/21/18

A Study of LY4170156 in Participants With Selected Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06400472 Org: User:
Start: 05/20/24 End: 04/30/27 Due: 04/30/28

A Study of LY3076226 in Participants With Advanced or Metastatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02529553 Org: User:
Start: 09/30/15 End: 03/28/18 Due: 03/28/19

Effect of Retatrutide Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone (TRANSCEND-T2D-1)

Phase: N/A Priority: Normal
NCT ID: NCT06354660 Org: User:
Start: 04/10/24 End: 02/28/26 Due: 02/28/27